Online citations, reference lists, and bibliographies.

Hematuria: Evaluation And Management

R. Bryant, J. Catto
Published 2011 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Hematuria is the presence of red blood cells in the urine and can be visible to the naked eye (macroscopic), detectable with microscopic analysis or found by dipstick testing of urine. Around 40% of patients with hematuria have a significant underlying cause regardless of the quantity of blood in the urine. As the presence of hematuria is common and there are often no clues as to the underlying cause, this condition comprises a large amount of the urological workload and should be regarded as a manifestation of urological malignancy until proven otherwise.1 While it is recognized that the contemporary urological approach for the investigation of hematuria may not always be evidence-based medicine,1 there are numerous high-quality studies confirming the prevalence of disease within patients with this condition.
This paper references
10.1016/S0090-4295(00)01124-9
A new diagnostic algorithm for the evaluation of microscopic hematuria.
J. Jaffe (2001)
Assessment of microscopic hematuria in adults.
M. Mcdonald (2006)
Urinary dosage of nuclear matrix protein 22 (NMP22) like biologic marker of transitional cell carcinoma (TCC): a study on patients with hematuria.
M. Paoluzzi (1999)
10.1159/000049809
Evaluation of the Clinical Value of Urinary NMP22 as a Marker in the Screening and Surveillance of Transitional Cell Carcinoma of the Urinary Bladder
R. Chahal (2001)
Can hematuria be a predictor as well as a symptom or sign of bladder cancer?
G. Friedman (1996)
[Evaluation of usefulness of urinary nuclear matrix protein 22 (NMP22) in the detection of urothelial transitional cell carcinoma].
Y. Miyoshi (2001)
10.1159/000282604
Clinical and radiological aspects of infiltrating transitional cell carcinoma of the kidney.
T. Igarashi (1994)
10.1016/S0022-5347(05)66080-6
Screening and monitoring for bladder cancer: refining the use of NMP22.
L. Ponsky (2001)
10.1056/NEJMCP012694
Clinical practice. Microscopic hematuria.
R. Cohen (2003)
10.1046/j.1464-410X.2002.02901.x
Is microscopic haematuria a urological emergency?
M. A. Khan (2002)
10.1016/S0094-0143(05)70055-0
Evaluation of asymptomatic microscopic hematuria.
G. Grossfeld (1998)
10.7326/0003-4819-114-9-821_9
Diagnostic Strategies for Common Medical Problems
R. Panzer (1991)
10.1148/RADIOLOGY.201.1.8816543
Transitional cell carcinoma of the renal pelvis: a retrospective look at CT staging with pathologic correlation.
J. A. Buckley (1996)
Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations.
G. Grossfeld (2001)
[Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--screening for urothelial cancer in patients with microscopic hematuria. NMP Study Group].
H. Akaza (1997)
10.1046/j.1442-2042.1999.06437.x
Urinary nuclear matrix protein 22 as a new marker for the screening of urothelial cancer in patients with microscopic hematuria
N. Miyanaga (1999)
10.1016/S0022-5347(05)67916-5
A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice.
M. Khadra (2000)
10.1016/S0090-4295(01)01307-3
The BTA stat test: a tumor marker for the detection of upper tract transitional cell carcinoma.
I. Walsh (2001)
10.1136/bmj.292.6521.681
Importance of occult haematuria found at screening.
C. Ritchie (1986)
10.1093/QJMED/89.11.845
Symptomless microhaematuria in schoolchildren: causes for variable management strategies.
J. Benbassat (1996)
10.1016/S0022-5347(01)62063-9
NMP22: a sensitive, cost-effective test in patients at risk for bladder cancer.
C. Zippe (1999)
10.1001/jama.1990.03440180081037
Evaluation of hematuria in adults.
J. Sutton (1990)
Diagnostic value of cytology of voided urine.
L. Koss (1985)
[Clinical assessment of patients with microscopic hematuria pointed out by mass screening examination].
Yasuo Nishikawa (1992)
10.1016/S0022-5347(05)64167-5
Prospective comparison of computerized tomography and excretory urography in the initial evaluation of asymptomatic microhematuria.
Christine L Gray Sears (2002)
10.1016/S0090-4295(01)00920-7
Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up.
G. Grossfeld (2001)
10.3949/CCJM.69.11.870
Hematuria: an algorithmic approach to finding the cause.
R. Mazhari (2002)
10.1001/jama.1979.03290280029021
Clinical importance of microhematuria.
R. Firfer (1979)
10.2214/AJR.172.6.10350278
Radiologic investigation of renal colic: unenhanced helical CT compared with excretory urography.
S. Sourtzis (1999)
10.1097/01.JU.0000134347.14643.AB
A side by side comparison of cytology and biomarkers for bladder cancer detection.
G. Schroeder (2004)
10.1111/j.1464-410X.2006.06406.x
Diagnostic tests used in the investigation of adult haematuria: a systematic review
M. Rodgers (2006)
Dipstick urinalysis screening, asymptomatic microhematuria, and subsequent urological cancers in a population-based sample.
R. Hiatt (1994)
10.1016/S0022-5347(01)61918-9
Noninvasive detection of bladder cancer with the BTA stat test.
D. Pode (1999)
10.1016/S0090-4295(02)01558-3
Utility of hematuria testing in patients with suspected renal colic: correlation with unenhanced helical CT results.
J. Luchs (2002)
10.1046/j.1464-410X.2003.04066.x
Is microscopic haematuria a urological emergency?
B. K. Sangtani (2003)
10.5489/CUAJ.600
Biomarkers for detection and surveillance of bladder cancer.
L. Budman (2008)
10.1136/bmj.b1324
Haematuria
Martijn Bakker (2009)
10.1148/RADIOLOGY.198.3.8628872
Small (< or = 3-cm) renal masses: detection with CT versus US and pathologic correlation.
C. Jamis-Dow (1996)
10.1046/J.1464-410X.1996.01975.X
Microscopic haematuria: urological investigation using a standard protocol.
S. Sultana (1996)
10.1016/J.EHBC.2005.09.008
Scottish Intercollegiate Guidelines Network
S. Twaddle (2005)
10.1016/S0031-3955(05)70553-8
Hematuria. An integrated medical and surgical approach.
L. Feld (1997)
10.1002/(SICI)1097-0339(199907)21:1<27::AID-DC8>3.0.CO;2-8
Utility of the BTA stat test kit for bladder cancer screening
J. Nasuti (1999)
10.1093/oxfordjournals.qjmed.a068471
A study to assess the efficacy of chemoprophylaxis in the prevention of endoscopy-related bacteraemia in patients aged 60 and over.
V. Vasanthakumar (1990)
10.1023/A:1017509418440
Evaluation of nuclear matrix protein 22 (NMP22) as a tumor marker in the detection of bladder cancer
Ö. Öge (2004)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar